Press Releases

CORONAVIRUS TEST WINS FUNDING FROM INNOVATE UK

Sugar based technology offers diagnosis on the spot in under 15 minutes

BARDA and Ortho Collaborate to Advance Development of High Specificity SARS-CoV-2 Antibody Tests

Panthera Biopartners appoints Chris Dodd as Executive VP of Business Development – Oncology and CNS

Chris Dodd has been appointed as the new Executive VP of Business Development – Oncology and CNS at Panthera Biopartners, an Independent Site Management Organisation based in Preston.

Association for Molecular Pathology Releases Preliminary Results to Nationwide SARS-CoV-2 Molecular Testing Survey

AMP releases preliminary results of its April 2020 SARS-CoV-2 testing survey for clinical laboratories.

Agendia Announces Data Presented at ASCO 2020 Demonstrating Importance of Further Classification of Breast Cancers to Enable Precise Prognosis and Treatment

Long-Term Follow Up Data from Groundbreaking MINDACT Study Continues to Demonstrate Clinical Utility of MammaPrint®

Creative Bioarray Launches Advanced Electrophysiological Technique for Screening Ion Channel Function and Regulation

Accumen Launches Hospital Lab Crisis Preparedness Program

Accumen’s team of laboratory experts has built a six-component, customizable program to help hospital and health system labs prepare for future pandemic or crisis situations.

MeMed Receives CE Mark for Two Pioneering Technologies: The MeMed BV™ Test and MeMed Key™ Point-of-Need Platform

Cutting-edge instrument platform and a novel host-immune response signature test rapidly distinguish between viral and bacterial infections to improve patient outcomes

Ubiquitome’s Liberty16 attracts Swiss giant

Ubiquitome has signed an exclusive agreement for Swiss headquartered DKSH to market and sell its mobile, battery powered COVID-19 tester, Liberty16, in several Asia Pacific countries. The agreement comes on the back of Ubiquitome recently receiving just over half a million dollars in New Zealand Government funding to help with increasing the manufacturing capacity for the Liberty16.

FDA Lists Bio-Rad’s CFX96 Dx Real-Time PCR System for IVD Testing

Bio-Rad Laboratories, Inc. announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19. The FDA listing extends access to the instrument to assay developers and testing laboratories in the U.S.

Creative Biolabs Unveils All-inclusive Antiviral Drug Discovery Services for SARS-CoV-2

To facilitate global research about drugs or vaccines for COVID-19, Creative Biolabs has launched a series of antiviral drug discovery services for SARS-CoV-2, including High-Throughput Screening and Antiviral Agents Discovery.

DermTech PLA Included in Peer Review Article of Novel Molecular Technologies for Melanoma Management with Potential to Address Current Gaps in Diagnostic Accuracy and Prognostication

Profacgen Released Lactic Acid Bacteria Fermentation Service

Creative BioMart Introduced Protein Network Construction and Topological Structure Analysis Service

Matexcel Updated Its Metal Powder Products Recently

EchelonDx Launches Mobile COVID-19 Testing and Vaccination Verification Application to Help Reopen Local Businesses, Restore Employment and Revive Economic Growth

Echelon Diagnostics launched the SafeKey™ Health Passport, a new mobile enterprise COVID-19 testing and vaccination verification application.

Accumen Develops New Channels for Critical COVID-19 Supplies and Recovery Resources for Hospitals and Health Systems

Accumen’s COVID-19 Resource Center provides access to its new testing capacity network, supplies of nasopharyngeal swabs, and face shields, as well as rapid response performance tools for hospital lab and imaging departments.

COVID-19 Total Antibody Test from Ortho Clinical Diagnostics Receives CE Mark

Proof-of-Concept Research Demonstrates Patients Reliably Perform Remote Self-Sampling of Concerning Moles Using DermTech’s Non-Invasive Adhesive Skin Collection Kit Under Physician Supervision via Telemedicine